Login to Your Account



Looking Ahead, States Begin Casting Biosimilar Safety Net

By Mari Serebrov
Washington Editor

Monday, January 28, 2013
regulatory.jpg

While the FDA is still waiting for its first biosimilar application to be submitted, a few states – with the encouragement of patient advocacy groups and the biopharma industry – are already casting a safety net for when interchangeable biologics hit the U.S. market.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription